Evan Loh, CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 199,500 shares at $1.98 ($393K) on 2022-12-12, disclosed to the SEC on 2022-12-14.
Tax-driven sale ($393k) by CEO — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.98 | 37,831 | $75K | 19.1% |
| 2 | $1.98 | 37,831 | $75K | 19.1% |
| 3 | $1.96 | 61,919 | $121K | 30.9% |
| 4 | $1.96 | 61,919 | $121K | 30.9% |
| Total | $1.97 avg | 199,500 | $393K | 100% |
| Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $753K | — | Filing → |